Stay informed with the latest updates for the inheritable blood disorders community.

Industry
Gene Therapy Licensing Agreement Between uniQure and CSL Now in Effect
Gene Therapy Licensing Agreement Between uniQure and CSL Now in Effect
Medical
Study Looks at Neuraxial Anesthesia and Postpartum Complications in Hemophilia
Study Looks at Neuraxial Anesthesia and Postpartum Complications in…
NBDF & Community
This national survey is designed to assess patient demographics, their satisfaction with the HTC’s core treatment team, its services, and care processes.
Take the National HTC Patient Satisfaction Survey
NBDF & Community
Wednesday Webinars
May 2021 Wednesday Webinars
Industry
Gene Therapy Helix
uniQure Announces End of Clinical Hold on Hemophilia B Gene Therapy…
NBDF & Community
New Chief Scientific Officer Joins NHF
New Chief Scientific Officer Joins NHF
NBDF & Community
DEI - Artwork of Diverse Group of People Men Women
A Message from NHF President and CEO
NBDF & Community
NHF Wednesday Webinars 2021
April 2021 Webinar Webinar Lineup
Advocacy & Legislative
How the American Rescue Plan Can Affect Your Healthcare Coverage
How the American Rescue Plan Can Affect Your Healthcare Coverage
Industry
uniQure Announces Findings from HCC Case Investigation in HOPE-B Trial for Gene Therapy
uniQure Announces Findings from HCC Case Investigation
NBDF & Community
NHF Letter to the Community
Letter to the Community
Industry
Ampoule bottles on an assembly line
Update to Hemlibra® (emicizumab-kxwh) USPI
COVID-19
Learn More About the COVID-19 Vaccines and ITP
Learn More About the COVID-19 Vaccines and ITP
NBDF & Community
Keri L. Norris
New Vice President of Health Equity, Diversity and Inclusion Joins NHF
NBDF & Community
NHF Announces Plans for 2021 NHF State of the Science Research Summit
NHF Announces Plans for 2021 NHF State of the Science Research Summit